ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
April 30, 2019 07:00 ET
|
Harrow Health, Inc.
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its participation at...
Harrow Health Announces Fourth Quarter 2018 Financial Results
March 12, 2019 16:01 ET
|
Harrow Health, Inc.
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2018. Fourth Quarter 2018 and Other Recent Notable Highlights: ...
Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019
March 04, 2019 07:00 ET
|
Harrow Health, Inc.
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending the 31st Annual ROTH Conference March 18-19, 2019 at The Ritz Carlton,...
Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019
February 28, 2019 07:00 ET
|
Harrow Health, Inc.
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release fourth quarter 2018 financial results after the close of trading on Tuesday, March 12,...
Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary
February 05, 2019 07:00 ET
|
Harrow Health, Inc.; Melt Pharmaceuticals, Inc.
SAN DIEGO and BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., an affiliated company of Harrow Health, Inc. (NASDAQ: HROW), today announced it has entered into definitive stock...